Document:

Exhibit 10.1 

 

AMENDMENT NO.1 TO 

CONSULTING AGREEMENT

 

This Amendment No. 1
to Consulting Agreement (“Amendment”) is entered into by and between Outlook Therapeutics, Inc. (“Company”)
and Scott Three Consulting, LLC (such entity, including its control persons, affiliates, directors and officers, “Consultant”)
(each herein referred to individually as a “Party,” or collectively as the “Parties”)
as of November 1, 2021 (“Effective Date”).

 

Company and Consultant entered
into that certain Consulting Agreement as of January 27, 2020 (the “Consulting Agreement”), and Company
and Consultant desire to amend Exhibit A of the Consulting Agreement pursuant to the terms of this Amendment. In consideration of
Consultant’s continued engagement with the Company and other good and valuable consideration, the receipt and sufficiency of which
is hereby acknowledged, and intending to be legally bound, the Parties agree as follows:

 

1.              Definitions

 

Capitalized terms used herein
and not otherwise defined shall have the same meaning as set forth in the Consulting Agreement.

 

2.              Amendments

 

The Parties hereby agree that
the Consulting Agreement shall be amended as follows:

 

In Section 2 of Exhibit A of
the Consulting Agreement, reference to “20 hours” shall be struck and replaced with “30 hours” so that the relevant
portion of Section 2 of Exhibit A of the Consulting Agreement shall read as follows:

 

“The Company and Consultant agree
that the Services: (A) will require up to 30 hours of work by Consultant per week for the Company, provided that Consultant may provide
more than 30 hours of work upon mutual agreement of the Parties . . . .”

 

The Services Fee in Section 3.A of
Exhibit A of the Consulting Agreement shall be increased from a monthly fee of $25,000 to a monthly fee of $37,500 for performing
the Services during the term of the Consulting Agreement.

 

3.              Continuation

 

Except as set forth herein,
all of the terms and conditions set forth in the Consulting Agreement, including its exhibits, are unchanged and shall remain in full
force and effect and are hereby ratified and confirmed by the Parties hereto. If any provision of this Amendment is inconsistent with
the Consulting Agreement, the Parties intend that the terms of this Amendment shall control solely to the extent required to make the
Consulting Agreement consistent with this Amendment.

 

4.              Construction
of Terms

 

This Amendment constitutes
the entire understanding between the Parties with respect to the subject matter hereof, and supersedes any other agreements or promises
made to Consultant by anyone with respect to this subject matter, whether oral or written. No modification to this Amendment shall be
valid unless in writing and signed by the Parties hereto.

 

5.              Governing
Law

 

This Agreement shall be governed
by the laws of the State of Delaware, without regard to the conflicts of law provisions of any jurisdiction.

 

    1

     

    

 

6.              Counterparts

 

This Amendment may be executed
in one or more counterparts, each of which shall be deemed to be an original, with the same force and effectiveness as though executed
in a single document.

 

7.              Effective
Date

 

The terms and conditions set
forth in this Amendment shall be effective as of the Effective Date.

 

 

IN WITNESS WHEREOF, the Parties
hereto have executed this Amendment as of November 8, 2021.

 

	SCOTT THREE CONSULTING, LLC	 	Outlook Therapeutics, Inc.
	 	 	 
	By:	/s/ Jeff Evanson	 	By:	/s/ C. Russell Trenary III
	 	 	 	 	 
	Name: 	Jeff Evanson	 	Name: 	C. Russell Trenary III
	 	 	 	 	 
	Title: 	President	 	Title: 	President & CEO

 

    2Exhibit 10.2

 

AMENDMENT NO.1 TO 

CONSULTING AGREEMENT

 

This Amendment No. 1
to Consulting Agreement (“Amendment”) is entered into by and between Outlook Therapeutics, Inc. (“Company”)
and The Dagnon Group LLC (such entity, including its control persons, affiliates, directors and officers, “Consultant”)
(each herein referred to individually as a “Party,” or collectively as the “Parties”)
as of November 1, 2021 (“Effective Date”).

 

Company and Consultant entered
into that certain Consulting Agreement as of January 27, 2020 (the “Consulting Agreement”), and Company
and Consultant desire to amend Exhibit A of the Consulting Agreement pursuant to the terms of this Amendment. In consideration of
Consultant’s continued engagement with the Company and other good and valuable consideration, the receipt and sufficiency of which
is hereby acknowledged, and intending to be legally bound, the Parties agree as follows:

 

1.              Definitions

 

Capitalized terms used herein
and not otherwise defined shall have the same meaning as set forth in the Consulting Agreement.

 

2.              Amendments

 

The Parties hereby agree that
the Consulting Agreement shall be amended as follows:

 

In Section 2 of Exhibit A of
the Consulting Agreement, reference to “20 hours” shall be struck and replaced with “30 hours” so that the relevant
portion of Section 2 of Exhibit A of the Consulting Agreement shall read as follows:

 

“The Company and Consultant agree
that the Services: (A) will require up to 30 hours of work by Consultant per week for the Company, provided that Consultant may provide
more than 30 hours of work upon mutual agreement of the Parties . . . .”

 

The Services Fee in Section 3.A of
Exhibit A of the Consulting Agreement shall be increased from a monthly fee of $25,000 to a monthly fee of $37,500 for performing
the Services during the term of the Consulting Agreement.

 

3.              Continuation

 

Except as set forth herein,
all of the terms and conditions set forth in the Consulting Agreement, including its exhibits, are unchanged and shall remain in full
force and effect and are hereby ratified and confirmed by the Parties hereto. If any provision of this Amendment is inconsistent with
the Consulting Agreement, the Parties intend that the terms of this Amendment shall control solely to the extent required to make the
Consulting Agreement consistent with this Amendment.

 

4.              Construction
of Terms

 

This Amendment constitutes
the entire understanding between the Parties with respect to the subject matter hereof, and supersedes any other agreements or promises
made to Consultant by anyone with respect to this subject matter, whether oral or written. No modification to this Amendment shall be
valid unless in writing and signed by the Parties hereto.

 

5.              Governing
Law

 

This Agreement shall be governed
by the laws of the State of Delaware, without regard to the conflicts of law provisions of any jurisdiction.

 

    1

     

    

 

6.              Counterparts

 

This Amendment may be executed
in one or more counterparts, each of which shall be deemed to be an original, with the same force and effectiveness as though executed
in a single document.

 

7.              Effective
Date

 

The terms and conditions set
forth in this Amendment shall be effective as of the Effective Date.

 

IN WITNESS WHEREOF, the Parties
hereto have executed this Amendment as of November 8, 2021.

 

	THE DAGNON GROUP, LLC	 	Outlook
Therapeutics, Inc.
	 	 	 
	By:	/s/ Terry J. Dagnon	 	By:	/s/ C. Russell Trenary III
	 	 	 	 
	Name: 	Terry J. Dagnon	 	Name: 	/s/ C. Russell Trenary III
	 	 	 	 
	Title: 	President	 	Title: 	President and Chief Executive Officer

 

    2Exhibit 10.1
​
​
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
This Amended and Restated Employment Agreement (the “Agreement”) is entered into by and between Roy W. Olivier, an individual (“you” or “your”), and Research Solutions, Inc., a Nevada corporation (the “Company”), and amends and restates that certain Executive Employment Agreement among the Company, Reprints Desk, Inc. and you, originally dated as of March 29, 2021.  This Agreement was executed by the parties on October 4, 2021 (the “Execution Date”) to be effective as of October 4, 2021 (the “Effective Date”).
In consideration of the mutual covenants and promises made in this Agreement, you and the Company agree as follows: 
1.Position and Responsibilities.  As of the Effective Date, you will serve as a full-time employee of the Company as the Company’s Chief Executive Officer and President (“CEO and President”).  As the CEO and President, you shall report directly to the Company’s Board of Directors (the “Board”).  You shall have the duties, responsibilities and authority that are customarily associated with such position and such other senior management duties as may reasonably be assigned by the Board, in each case, in accordance with Company policy as set forth from time to time by the Board and subject to the terms hereof.  Additionally, at the request of the Board, you shall also serve, without additional compensation, as the CEO and President of the Company’s current and future subsidiaries.  You shall devote substantially all of your business time and commit your best efforts to the Company’s business.  Your duties shall be primarily performed at locations determined by the Board from time to time and will be subject to requisite business travel.  Nothing herein shall preclude you from (i) serving as a member of the board of directors or advisory boards (or their equivalents in the case of a non-corporate entity) of non-competing businesses and charitable organizations subject to your notifying the Board of such activities, (ii) engaging in charitable activities and community affairs, and (iii) managing your personal investments and affairs; provided, however, that the activities set out in clauses (i), (ii) and (iii) shall be limited by you so as not to materially interfere, individually or in the aggregate, with the performance of your duties and responsibilities hereunder.
2.Term.  Your employment with the Company as CEO and President shall be for the period commencing on the Effective Date and ending on the date immediately prior to the third anniversary of the Effective Date (the “Expected Term”), or such earlier date that your employment is terminated in accordance with the provisions of this Agreement.  Notwithstanding the foregoing, your employment will be “at-will” at all times, and either you or the Company may terminate such employment at any time and for any reason, with or without Cause (as defined below), in each case subject to the terms and provisions of this Agreement.  The terms of Sections 8 through 15 and Section 18 shall each survive any termination or expiration of this Agreement or of your employment.

	​
	​
	​

	​
	​
	​

​

3.Salary, Bonus, Equity Incentives and Other Benefits.  For the avoidance of doubt, the Board may delegate its authority and responsibilities under this Section 3 to a committee of members of the Board, subject to the requirements of applicable law.
(a)Base Salary.  During your employment as CEO and President under this Agreement, you will be paid an annual base salary at least equal to $371,520 (the “Base Salary”) for your services as CEO and President, payable in the time and manner that the Company customarily pays its employees.  Your Base Salary shall also be reviewed annually by the Board and may be adjusted by the Board in its discretion.
(b)Bonus Compensation.  You are eligible to participate in the Company’s executive bonus plans as determined by the Board. 
(c)Equity Incentives.  You will receive, in connection with your service as CEO and President, equity incentive awards as determined by the Board.
4.Business Expenses.  During your employment as CEO and President under this Agreement, you will be reimbursed for all reasonable business expenses (including, but without limitation, travel expenses) upon the properly completed submission of requisite forms and receipts to the Company in accordance with the Company’s expense reimbursement policies as in effect from time to time.
5.Limitation on Payments.  In the event that it is determined that any payment or distribution of any type to or for your benefit made by the Company, by any of its affiliates, by any person who acquires ownership or effective control or ownership of a substantial portion of the Company’s assets (within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended, and the regulations thereunder (the “Code”)) or by any affiliate of such person, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise (the “Total Payments”), would be subject to the excise tax imposed by Section 4999 of the Code (and/or would not deductible under Code Section 280G) or any interest or penalties with respect to such excise tax (such excise tax, together with any such interest or penalties, are collectively referred to as the “Excise Tax”), then such payments or distributions or benefits shall be payable as to such lesser amount (but while maximizing the present value of the payments and benefits to be provided to you or retained by you) which would result in no portion of such payments or distributions or benefits being subject to the Excise Tax.  Unless you and the Company agree otherwise in writing, any determination required under this Section 5 shall be made in writing by a qualified independent accountant selected by the Company (the “Accountant”) whose determination shall be conclusive and binding.  You and the Company shall furnish the Accountant such documentation and documents as the Accountant may reasonably request in order to make a determination. The Company will pay all fees, expenses and other costs associated with retaining the Accountant for the purposes of this Section 5.
Notwithstanding the foregoing, however, and solely in the event that no stock of the Corporation was readily tradeable on an established securities market, or otherwise, immediately before a Change of Control, at your election and provided you cooperate and timely execute any requisite documentation including required waivers of compensation, the Company agrees (if permitted under applicable law) to submit the Total Payments to a vote of its stockholders in accordance 

	​
	-2-
	​

	​
	​
	​

​

with Section 280G of the Code and the Treasury regulations and related guidance promulgated thereunder such that, if approved, none of the Total Payments shall be deemed to be parachute payments as defined under the Code.
If you submit your payments and benefits to a 280G stockholder vote and the requisite approval is not obtained or there is otherwise a reduction of Total Payments in accordance with this Section 5, then the reduction of Total Payments will occur in the manner you elect in writing prior to the date of payment; provided, however, that if the manner elected by you pursuant to this sentence could in the opinion of the Company result in any of the Total Payments becoming subject to Section 409A of the Code, then the following sentence will instead apply.  If any of the Total Payments is subject to Section 409A of the Code, if you fail to elect an order under the preceding sentence or if no such election is permitted, then the reduction will occur in the following order: (i) cancellation of acceleration of vesting of any equity compensation awards for which the exercise price (if any) exceeds the then-fair market value of the underlying equity compensation award; (ii) reduction of cash payments (with such reduction being applied to the payments in the reverse order in which they would otherwise be made (that is, later payments will be reduced before earlier payments)); and (iii) cancellation of acceleration of vesting of equity compensation awards not covered under (i) above; provided, however, that in the event that acceleration of vesting of equity compensation awards is to be cancelled, such acceleration of vesting will be cancelled in the reverse order of the date of grant of such equity compensation awards (that is, later equity compensation awards will be canceled before earlier equity compensation awards). “Equity compensation awards” means (i) all shares of stock; (ii) all options and other rights to purchase shares of stock; (iii) all stock units, performance units or phantom shares whose value is measured by the value of shares of stock; and (iv) all stock appreciation rights whose value is measured by increases in the value of shares of stock.
6.Employee Benefit Programs.  You will be eligible to participate in all employee benefit programs and perquisites in a manner commensurate with similarly situated employees of the Company and its controlled affiliates, subject to satisfying the applicable eligibility requirements. The Company may amend, modify or terminate these benefits at any time and for any reason.  
7.Consequences of Termination of Employment.  Unless the Company and you otherwise agree in writing, upon termination of your employment as CEO and President for any reason, you shall be deemed to have immediately resigned from all positions as an officer (and/or director, if applicable) with the Company (and its respective affiliates) as of your last day of employment (the “Termination Date”).  Upon termination of your employment as CEO and President for any reason, you shall receive payment or benefits from the Company covering the following: (i) all unpaid salary and unpaid vacation accrued through the Termination Date, (ii) any payments/benefits to which you are entitled under the express terms of any applicable Company employee benefit plan, (iii) any unreimbursed valid business expenses for which you have submitted (or timely submit) properly documented reimbursement requests in accordance with Section 4, and (iv) your then outstanding equity compensation awards will be governed by their applicable terms (collectively, (i) through (iv) are the “Accrued Pay”).  You may also be eligible for other post-employment payments and benefits as provided in this Agreement.  For purposes of this Agreement, “Qualifying Termination” means (1) either (a) a termination of your employment as CEO and President without Cause by the Company, or (b) your resignation as CEO and 

	​
	-3-
	​

	​
	​
	​

​

President for Good Reason, and (2) that you have timely complied with the release of claims requirements of Section 7(e).  For the avoidance of doubt, a termination of your employment due to death or Disability is addressed in Section 7(d) below and will not be considered a Qualifying Termination.
(a)For Cause.  For purposes of this Agreement, your employment may be terminated by the Company for “Cause” as a result of the occurrence of one or more of the following:
(i)your conviction of, or a plea of guilty or nolo contendere to, a felony or other crime involving moral turpitude, dishonesty, breach of trust or physical harm to any person;
(ii)your failure to comply in any material respect with the terms of this Agreement and the Confidentiality Agreement (as defined below) and/or the policies and procedures of the Company or a Company affiliate at which you serve as an officer and/or director, the violation of which results in material harm to the Company, or your repeated failure to carry out any reasonable directive of the Board concerning the operations of the Company or its affiliates; 
(iii)your acts (or omissions) of fraud, theft, embezzlement, misappropriation of trade secrets or other illegal conduct in your performance of duties for the Company or a Company affiliate; or
(iv)your engaging in any act of dishonesty, disloyalty, moral turpitude, or any other conduct in connection with your responsibilities to the Company and/or any of its affiliates that causes material harm to the Company or any Company affiliate.
Prior to your termination for Cause, you will be provided with written notice from the Company describing the conduct forming the basis for the alleged Cause.  To the extent curable (as determined by the Board in its discretion), you will have an opportunity of twenty (20) days to cure such conduct and consequences before the Company may terminate you for Cause.  Any termination for “Cause” will not limit any other right or remedy the Company may have under this Agreement or otherwise.
In the event your employment is terminated by the Company for Cause you will be entitled only to your Accrued Pay, and you will be entitled to no other compensation from the Company.  
For the avoidance of doubt, terminations of employment due to death or Disability, which are addressed in Section 7(d) below, are not terminations for Cause.
(b)Qualifying Termination.  The Company may terminate your employment as CEO and President without Cause at any time and for any reason with notice or you may resign your employment as CEO and President for Good Reason upon thirty (30) days advance written notice.  If your employment as CEO and President is terminated due to a Qualifying Termination, then you will be eligible to receive the items set forth below subject to your timely compliance with Section 7(e) and further provided that no payments for such Qualifying Termination shall be 

	​
	-4-
	​

	​
	​
	​

​

made until on or after the date of a “separation from service” within the meaning of Code Section 409A.
(i)If the Company terminates your employment as CEO and President between July 1 and September 15 of a given fiscal year, the Company shall pay you for any accrued but unpaid bonus payable pursuant to Section 3(b) above with respect to the immediately preceding completed fiscal year (with such payment occurring at the same time that the final bonus payment would be made if you had remained employed and taking into account any interim payments previously made) (the “Earned Bonus”);
(ii)The Company shall pay you a pro rata portion of any bonus payable pursuant to Section 3(b) above in respect of the fiscal year in which the Termination Date occurs, if any, pro-rated for the number of days in such fiscal year in which you were employed over the number of total calendar days in such fiscal year (with such payment occurring at the same time that the bonus payment would be made if you had remained employed) (the “Pro Rata Bonus”);
(iii)Subject to Section 11 below, the Company shall provide you with cash payments over the lesser of (1) the eighteen (18)-month period following your Termination Date and (2) the period from your Termination Date through the end of the expected term (as applicable, the “Severance Period”) equal in the aggregate to your then current annual Base Salary (prior to any reduction giving rise to Good Reason) pro-rated for the Severance Period.  The cash payments provided by this subpart (iii) shall be paid to you in substantially equal installments payable under regular payroll practices over the Severance Period, provided that once such payments commence, they will include any unpaid amounts accrued from your Termination Date;
(iv)The Company shall continue to pay the Company portion of the premiums for your Company group medical insurance coverage (or alternative comparable coverage) during the Severance Period provided you continue to timely pay the same portion (if any) of the necessary premium that you were responsible to pay as of immediately before your Termination Date.  In all cases, the coverage (and/or reimbursement payments) provided in this subpart shall immediately terminate if you are offered comparable coverage in connection with your employment by another employer; and
(v)For purposes of this Agreement, you may resign your employment from the Company as CEO and President for “Good Reason” within ninety (90) days after the date that any one of the following events described in subparts (1) through (3) (any one of which will constitute “Good Reason”) has first occurred without your written consent.  Your resignation for Good Reason will only be effective if the Company has not cured or remedied the Good Reason event within thirty (30) days after its receipt of your written notice (such notice shall describe in reasonable detail the basis and underlying facts supporting your belief that a Good Reason event has occurred).  Such notice of your intention to resign for Good Reason must be provided to the Company within sixty (60) days of the initial existence of a Good Reason event.  Failure to timely provide such written notice to the Company or failure to timely resign your employment for Good Reason means that you will be deemed to have consented to and waived the Good Reason event.  If the Company does timely cure or remedy the Good Reason event, then you may either resign your employment without Good Reason or you may continue to remain employed subject to the terms of this Agreement. “Good Reason” means:

	​
	-5-
	​

	​
	​
	​

​

(1)During any period in which you are serving as CEO and President, you have incurred a material diminution in your responsibilities, duties or authority, or following a Change in Control you incur either a change in your title or position or reporting relationship (provided, however, that following a Change in Control, the fact that the Company may have become a subsidiary or division of another entity shall not by itself constitute Good Reason);
(2)During any period in which you are serving as CEO and President, you have incurred a material diminution in your Base Salary;
(3)The Company has breached a material provision of this Agreement; or
(4)The Company’s requirement that you relocate your principal workplace from Winter Park, Florida.
For the avoidance of doubt, this Section 7(b) does not apply to terminations of employment due to death or Disability which are addressed in Section 7(d) below.
(c)Voluntary Termination.  In the event you voluntarily terminate your employment with the Company as CEO and President without Good Reason, you will be entitled to receive only your Accrued Pay.  You will be entitled to no other compensation from the Company in connection with your role as CEO and President.  The Company requests that you provide at least thirty (30) days’ advance written notice of your intention to resign without Good Reason.  In the event that you provide to the Company with such thirty (30) days’ advance written notice the Company shall have the option, in its sole discretion, to make your termination effective at any time prior to the end of such notice period as long as the Company pays you all compensation to which you are entitled up through the last day of the thirty (30)-day notice period.  For the avoidance of doubt, this Section 7(c) does not apply to terminations of employment due to death or Disability which are addressed in Section 7(d) below.
(d)Death or Disability.  In the event your employment with the Company as its CEO and President is terminated as a result of your death or is terminated by the Company due to your Disability, then you or your estate will be eligible to receive: (i) your Accrued Pay and (ii) the Earned Bonus (if applicable and to the extent not previously paid in respect of the immediately preceding fiscal year).  For purposes of this Agreement, “Disability” is defined to occur when you are unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for more than ninety (90) consecutive days or more than one hundred and twenty days (120) in any twelve-month period.
(e)Release of Claims.  As a condition to receiving (and continuing to receive) the payments and benefits provided in Section 7(b), you must (i) within not later than forty-five (45) days after your Termination Date, execute (and not subsequently revoke) and deliver to the Company a general release of claims (the “Release”) in a form acceptable to the Company, and (ii) remain in full compliance with such Release.

	​
	-6-
	​

	​
	​
	​

​

(f)No Offset. There shall be no offset obligation in the event you commence employment as an executive and/or officer with any other company or organization during the Severance Period.
(g)Termination of Benefits. In the event that, during the Severance Period, (i) you breach any of the provisions of the Confidentiality Agreement, or (ii) you directly or indirectly, become employed by or undertake any independent contractor relationship with, or otherwise provide services in any capacity to, or become a stockholder, member or other equity holder of, a Competitor, then the Board may, in its sole and absolute discretion, terminate all remaining payments contemplated by Sections 7(b)(ii), 7(b)(iii) and 7(b)(v), immediately upon prior written notice. For purposes of this Agreement, “Competitor” means any entity that, as its principal business, enables the discovery, acquisition and management of scholarly journal articles, book chapters and other content in scientific, technical and medical research.
8.Confidential Information and Inventions Assignment Agreement; Confidentiality.  You agree and acknowledge that the terms of the Confidential Information and Inventions Assignment Agreement (the “Confidentiality Agreement”) that you previously executed shall remain in full force and effect.
9.Assignability; Binding Nature.  Commencing on the Effective Date, this Agreement will be binding upon you and the Company and your respective successors, heirs, and assigns.  This Agreement may not be assigned by you except that your rights to compensation and benefits hereunder, subject to the limitations of this Agreement, may be transferred by will or operation of law.  No rights or obligations of the Company under this Agreement may be assigned or transferred except in the event of a merger or consolidation in which the Company is not the continuing entity, or the sale or liquidation of all or substantially all of the assets of the Company provided that the assignee or transferee is the successor to all or substantially all of the assets of the Company and assumes the Company’s obligations under this Agreement contractually or as a matter of law Your rights and obligations under this Agreement shall not be transferable by you by assignment or otherwise provided, however, that if you die, all amounts then payable to you hereunder shall be paid in accordance with the terms of this Agreement to your devisee, legatee or other designee or, if there be no such designee, to your estate.
10.Governing Law; Arbitration.  This Agreement will be deemed a contract made under, and for all purposes shall be construed in accordance with, the laws of the state of Florida.  Any controversy or claim relating to this Agreement or any breach thereof, and any claims you may have arising from or relating to your employment with the Company, will be settled solely and finally by arbitration as provided in the Confidentiality Agreement provided that this Section 10 shall not be construed to eliminate or reduce any right the Company or you may otherwise have to obtain a temporary restraining order or a preliminary or permanent injunction to enforce any of the covenants contained in this Agreement before the matter can be heard in arbitration.   
11.Taxes.  Anything to the contrary notwithstanding, all payments made by the Company hereunder to you or your estate or beneficiaries will be subject to tax withholding pursuant to any applicable laws or regulations.  This Agreement and its payments and benefits are intended to comply with (or be exempt from) the requirements of Section 409A of the Code and 

	​
	-7-
	​

	​
	​
	​

​

will be interpreted and administered in accordance with such intention.  In the event this Agreement or any benefit paid to you hereunder is deemed to be subject to Section 409A of the Code, you consent to the Company adopting such conforming amendments or taking such actions as the Company deems necessary, in its reasonable discretion, to comply with Code Section 409A and avoid the imposition of taxes under Code Section 409A.  Notwithstanding any provision in the Agreement to the contrary, if upon your “separation from service” within the meaning of Code Section 409A, you are then a “specified employee” (as defined in Code Section 409A), then to the extent necessary to comply with Code Section 409A and avoid the imposition of taxes under Code Section 409A, the Company shall defer payment of “nonqualified deferred compensation” subject to Code Section 409A payable as a result of and within six (6) months following such “separation from service” under this Agreement until the earlier of (i) the first business day of the seventh month following your “separation from service,” or (ii) ten (10) days after the Company receives written notification of your death.  Any such delayed payments shall be made without interest.  Additionally, the reimbursement of expenses or in-kind benefits provided pursuant to this Agreement shall be subject to the following conditions: (1) the expenses eligible for reimbursement or in-kind benefits in one taxable year shall not affect the expenses eligible for reimbursement or in-kind benefits in any other taxable year; (2) the reimbursement of eligible expenses or in-kind benefits shall be made promptly, subject to the Company’s applicable policies, but in no event later than the end of the year after the year in which such expense was incurred; and (3) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit.  The Company will have no liability to you or any other person if any amounts paid or payable are subject to the additional tax and/or penalties and/or interest under Code Section 409A.  To the extent any amount constituting “nonqualified deferred compensation” subject to Code Section 409A would become payable by reason of a Change of Control, it shall become payable only if the event or circumstances constituting the Change of Control would also constitute a change in the ownership or effective control of the Company, or a change in the ownership of a substantial portion of the Company’s assets, within the meaning of Code Section 409A.  For purposes of Code Section 409A, each payment made to you under this Agreement will be designated as a separate payment.
12.Entire Agreement.  Except as otherwise specifically provided in this Agreement, this Agreement (and its Exhibits) contains all the legally binding understandings and agreements between you and the Company pertaining to the subject matter of this Agreement and supersedes all such agreements, whether oral or in writing, previously entered into between the parties.
13.Covenants.
(a)General.  As a condition of this Agreement and also to your receipt of any post-employment benefits, you agree that you will fully and timely comply with all of the covenants set forth in this Section 13(a) (which shall survive your termination of employment and termination or expiration of this Agreement):
(i)You will fully comply with all obligations under the Confidentiality Agreement and further agree that the provisions of the Confidentiality Agreement shall survive any termination or expiration of this Agreement or termination of your employment or any subsequent service relationship with the Company;

	​
	-8-
	​

	​
	​
	​

​

(ii)Within ten (10) days of the Termination Date (or earlier if specified in the Confidentiality Agreement), you shall return to the Company all Company confidential information including, but not limited to, intellectual property, etc. and you shall not retain any copies, facsimiles or summaries of any Company proprietary information;
(iii)Except for truthful statements made in compliance with legal process or governmental inquiry, you will not at any time during the period of your employment with the Company and for one year after the Termination Date, make (or direct anyone to make) any disparaging statements (oral or written) about the Company, or any of its affiliated entities, officers, directors, employees, stockholders, representatives or agents, or any of the Company’s (or its affiliates) products or services or work-in-progress, that are harmful to their businesses, business reputations or personal reputations; and
(iv)You agree that you shall reasonably cooperate with the Company and its affiliates and representatives before and after the Termination Date in connection with any action, investigation, proceeding, litigation or otherwise with regard to matters in which you knowledge as a result of your service. The Company will reimburse you for reasonable out-of-pocket expenses incurred in connection with such cooperation if such cooperation occurs after your Termination Date.
(b)Administrative.  You also agree that you will fully and timely comply with all of the covenants set forth in this Section 13(b) (which shall survive your termination of employment and termination or expiration of this Agreement):
(i)Within ten (10) days of the Termination Date, you shall return to the Company all Company (and Company affiliate) property including, but not limited to, computers, cell phones, pagers, keys, business cards, etc.;
(ii)Within thirty (30) days of the Termination Date, you will submit any outstanding expense reports to the Company on or prior to the Termination Date; and
(iii)As of the Termination Date, you will no longer represent that you are an officer, director or employee of the Company or any Company affiliate and you will immediately discontinue using your Company (and any Company affiliate) mailing address, telephone, facsimile machines, voice mail and e-mail.
(c)Non-Competition; Non-Solicitation.  You acknowledge and agree that the nature of your position gives you access to and knowledge of Confidential Information (as defined in the Confidentiality Agreement) and places you in a position of trust and confidence with the Company. You further acknowledge and agree that the Confidential Information is of great competitive importance and commercial value to the Company, and that improper use or disclosure by you is likely to result in unfair or unlawful competitive activity.  Because of the Company’s legitimate business interest as described in this Agreement and the good and valuable consideration offered to you, the receipt and sufficiency of which you hereby acknowledge, during the two (2)-year period following your Termination Date, you agree and covenant not to (i) contribute your knowledge and/or services, directly or indirectly, in whole or in part, as an employee, employer, owner, operator, manager, advisor, consultant, contractor, agent, partner, director, stockholder, 

	​
	-9-
	​

	​
	​
	​

​

officer, volunteer, intern, or any other similar capacity to any Competitor within any jurisdiction in which the Company conducted business as of the Termination Date, or (ii) divert or attempt to divert from the Company any business of any kind, including without limitation, the solicitation of or interference with any of its customers, clients, members, business partners or suppliers.
(d)Equitable Relief.  You acknowledge that in the event of (i)  a violation of any of the covenants contained in Section 13 of this Agreement or (ii)  the termination by the Company of your employment for Cause as provided in Section 7(a), the Company would as a result sustain irreparable harm for which monetary damages are insufficient, and, therefore, you agree that in addition to any other remedies which the Company may have, the Company shall be entitled to seek equitable relief including specific performance and injunctions restraining you from committing or continuing any such violation.
14.Offset.  Notwithstanding the provisions of Section 7(f), any severance or other payments or benefits made to you under this Agreement may be reduced, in the Company’s reasonable discretion, by any amounts you owe to the Company or as will be needed to satisfy any future co-payments you would need to make for continuing post-termination benefits, provided however that any such offsets do not violate Code Section 409A or any other provision of applicable law.
15.Notice.  Any notice that the Company is required to or may desire to give you shall be given by personal delivery, recognized overnight courier service, email, facsimile or registered or certified mail, return receipt requested, addressed to you at your address of record with the Company, or at such other place as you may from time to time designate in writing.  Any notice that you are required or may desire to give to the Company hereunder shall be given by personal delivery, recognized overnight courier service, email, facsimile or by registered or certified mail, return receipt requested, addressed to the Company’s General Counsel at its principal office, or at such other office as the Company may from time to time designate in writing.  The date of actual delivery of any notice under this Section 15 shall be deemed to be the date of delivery thereof.
16.Waiver; Severability.  No provision of this Agreement may be amended or waived unless such amendment or waiver is agreed to by you and the Company in writing.  No waiver by you or the Company of the breach of any condition or provision of this Agreement will be deemed a waiver of a similar or dissimilar provision or condition at the same or any prior or subsequent time.  Except as expressly provided herein to the contrary, failure or delay on the part of either party hereto to enforce any right, power, or privilege hereunder will not be deemed to constitute a waiver thereof.  In the event any portion of this Agreement is determined to be invalid or unenforceable for any reason, the remaining portions shall be unaffected thereby and will remain in full force and effect to the fullest extent permitted by law.
17.Voluntary Agreement.  You acknowledge that you have been advised to review this Agreement with your own legal counsel and other advisors of your choosing and that prior to entering into this Agreement, you have had the opportunity to review this Agreement with your attorney and other advisors and have not asked (or relied upon) the Company or its counsel to represent you or your counsel in this matter.  You further represent that you have carefully read and understand the scope and effect of the provisions of this Agreement and that you are fully 

	​
	-10-
	​

	​
	​
	​

​

aware of the legal and binding effect of this Agreement.  This Agreement is executed voluntarily by you and without any duress or undue influence on the part or behalf of the Company.  
18.Clawback.  If the Company is required to restate any of its financial statements, then the Board shall be entitled to recover or require reimbursement of any annual bonus made to you, less applicable taxes withheld.

	​
	-11-
	​

	​
	​
	​

​

Please acknowledge your acceptance and understanding of this Agreement by signing and returning it to the undersigned.  A copy of this signed Agreement will be sent to you for your records.
	AGREED:
	​

	​
	​

	RESEARCH SOLUTIONS, INC.
	ROY W. OLIVIER
​

	​
	​

	BY: ​ ​
	​ ​​

	NAME: Eugene Robin
TITLE: Comp. Committee Chairman
​
	(signature)

​

	​
	-12-
	​

	​
	​
	​

​

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}]]